BeautyHealth’s SkinStylus™ Receives New FDA Clearance for Facial Acne Scarring

 Now the only microneedling device FDA-cleared for use on both the face and abdomen

Milestone achievement in just five months since BeautyHealth’s acquisition of the brand

The Beauty Health Company (NASDAQ:SKIN), home to hero brand Hydrafacial, today announced the U.S. Food and Drug Administration (FDA) has cleared its SkinStylus™ microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen.

https://finance.yahoo.com/news/beautyhealth-skinstylus-receives-fda-clearance-120000179.html